Lombard Medical Limited
Lombard Medical Limited is a UK-based medical device company focused solely on the minimally invasive treatment of aortic disease. In partnership with MicroPort Endovastec, we now offer the low-profile MinosTM AAA stent graft, the HerculesTM TAA stent graft and the CastorTM Branched Thoracic stent graft in addition to our own AorfixTM and AlturaTM stent grafts, giving us a broad portfolio. Lombard’s latest innovation is the Fenestrated AlturaTM stent graft which launches us into the FEVAR market with the only available 14F fenestrated device, adding even more treatment options to the physician’s armamentarium.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
Our mission is to a be a global provider and champion of innovative solutions for the treatment of vascular disease.
We are passionately committed to serving clinicians and patients and consistently achieve exceptional results in everything we do.
We will enhance clinical outcomes, improve quality of life for patients and provide rewarding careers for our people.
History
- 1994 Lombard Medical is founded
- 1998 The birth of AorfixTM EVAR stent graft
- 2001 AorfixTM is CE marked
- 2004 AorfixTM is CE marked for 0-65° angulated necks
- 2007 AorfixTM US Pythagoras clinical trial begins
- 2009 AorfixTM is CE marked for 0-90° angulated necks
- 2012 AorflexTM Generation Three delivery system introduced
- 2013 AorfixTM approved by FDA
- 2014 AorfixTM approved in Japan
- 2016 IntelliflexTM Generation Four delivery system introduced
- 2016 Acquisition of AlturaTM EVAR stent graft
- 2018 Partnership with MicroPort Endovastec
- May 2020 European launch of HerculesTM TEVAR stent graft
- May 2020 European launch of MinosTM EVAR stent graft
- Oct 2020 First Fenestrated AlturaTM FEVAR stent graft
- Feb 2021 European launch of CastorTM branched TEVAR stent graft